Glivec the cancer cure.


On Friday, April 5th, 2013. Joey Lund created a interesting blog on Novartis which is a pharmaceutical company that offers: innovative medicines, vaccines, eye care, diagnostic tools, over the counter medicine and animal health car products. The blog contained brief information on the cancer treatment called "glivec" and how it was intended to be a global product. Her blog was well constructed, but its just lacked a bit of information on the insight of what the medicine was all about and how it was being used in India and other countries. I didn't really get the overall objective of a point that was trying to be proven in the blog, but it was creative and something unique.

Novartis attempted  patented glivec, but was denied by the supreme court of the worlds largest democracy India. India rejected its medical innovation, saying that glivec wasn't a new medicine but an amended product of its earlier version. India being the largest pharmaceutical supplier for general medicicines as stated in Joey's blog, closely identified the medicine and basically incinuated that glivec wasn't advanced enough to be patented in their country. I could see how this could be, as India feels like its" top cheif" in the global medicine production and wont settle for anything other than great. Glivec, which is a life saving medicine for certain forms of cancer is patented in just about 40 countries, Russia, China, and Taiwan just to name a few. It is given free to just about 99% of its patients, through novartis oncology access program. "Novartis has never been granted an original patent for Glivec in India. We strongly believe that original innovation should be recognized in patents to encourage investment in medical innovation especially for unmet medical needs," said Ranjit Shahani, Vice Chairman and Managing Director, Novartis India Limited. "We brought this case because we strongly believe patents safeguard innovation and encourage medical progress, particularly for unmet medical needs. This ruling is a setback for patients that will hinder medical progress for diseases without effective treatment options."-Novartis.com

 "Where there is no patent protection there is no investment.  And where there is no investment there is no innovation.Minus patent protection, an innovator company can't earn back what it invested in R&D, ergo they can't reinvest their profits in further R&D—further delaying crucial incremental innovation, which is how medical progress is made"- Noah Pines

Overall, I feel as if her blog was good and it was something new about whats going on in other countries.